Yatharth Hospital & Trauma Care Services Limited – Investor Presentation Summary

Key Operational Highlights

  • Operational bed capacity reached 2,655 beds including newly acquired under-construction hospital in Gurugram (250 beds)
  • Occupancy based on currently operational census beds (newer hospitals still ramping up)
  • Increasing volumes, faster discharges and rising ARPOB as new capacity comes online
  • Newer hospitals (Greater Faridabad, New Delhi Model Town, Faridabad Sector-20, and Agra) becoming meaningful part of business

Key drivers of operational performance: New capacity coming online, cluster-based strategy building density and market leadership, broader high-value specialty base

Financial Highlights

Revenue: ₹4,314 million (Q2FY27), ₹8,241 million (H1FY27)

EBITDA: ₹1,020 million (Q2FY27), ₹1,937 million (H1FY27)

PAT: ₹485 million (Q2FY27), ₹939 million (H1FY27)

EBITDA Margin: 23.6% (Q2FY27), 23.5% (H1FY27)

YoY/QoQ comparison: Revenue grew 52% YoY in Q2FY27 and 10% QoQ; PAT grew 17% YoY in Q2FY27 and 7% QoQ; H1FY27 revenue grew 52% YoY while PAT grew 13% YoY

Drivers of financial performance: Higher revenue growth from new capacity, operational efficiencies as newer hospitals ramp up

Key Risks: Ramp-up of newer hospitals, market preferences, exposure to market risks, technological implementation changes

Balance Sheet Snapshot

Net Debt/Equity: Not explicitly specified

Reserves: Other equity of ₹17,794 million as of Sep-26

Current Assets/Liabilities: Current assets ₹8,587 million vs current liabilities ₹2,678 million as of Sep-26

Working Capital/Leverage Metrics: Trade receivables ₹4,640 million; Inventories ₹231 million; Trade payables ₹1,079 million

Financial Health Insights: Strong cash position with cash and cash equivalents of ₹2,755 million; Total assets increased to ₹25,908 million from ₹22,815 million in Mar-26

Capex & Cash Flow Health

Capital Expenditure: Capital work-in-progress of ₹2,421 million as of Sep-26 (increased from ₹1,021 million in Mar-26)

Free Cash Flow: Not explicitly specified

Operating Cash Flow: Not explicitly specified

Net Debt Movement: Borrowings increased to ₹4,507 million (current + non-current) from ₹2,534 million in Mar-26

Investment Rationale: Focus on capacity expansion including Gurugram hospital operationalization by H1FY28, technology upgrades

Strategic & R&D Initiatives

Investments in Innovation: Cluster-based strategy building density and market leadership; diversifying specialty base across hospitals; medical value travel expansion

Expected impact on growth: New Gurugram facility strategically located in Central Gurugram within dense high-income catchment area; catering to domestic & international patients with proximity to IGI airport

Strategic Rationale: Partnership with Advent International bringing US$109 billion AUM and 35+ years healthcare experience; accelerating bed capacity target to 7,000-8,000 beds from 5,000 beds in 3-5 years

Industry Trends & Business Environment

Macro/Industry Trends: Growing healthcare needs of both domestic & international patients; medical value travel as growing growth lever

Impact on Company: Exclusive hospital partner to Noida International Airport; global OPD & brand awareness activities in Uzbekistan, Bangladesh, Ethiopia, Kenya, Nigeria, Saudi Arabia, Nepal, Chad, Iraq

Management Commentary & Growth Outlook

Strategic Outlook: Tyagi family remains largest shareholder and continues to guide long-term vision; existing leadership team continuity with acceleration

FY Guidance: Target of 7,000-8,000 beds with Advent partnership within 3-5 years (accelerated from 5,000 beds)

Market Share Targets: Building North India's trusted healthcare platform; cluster-based strategy for market leadership

Risks and Opportunities: Newer hospitals (New Delhi, Faridabad Sec-20, Agra and Gurugram) yet to fully ramp up; census beds will increase progressively

ESG Updates

Not Specified

Digital Transformation

Not Specified